[9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:1), (9R,9′R)-rel-
-
![[9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:1), (9R,9′R)-rel- structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220811/9f1704ee53794511a8fe74e164ba2441.png "[9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:1), (9R,9′R)-rel-")
[9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:1), (9R,9′R)-rel-
structure -
-
CAS No:
62211-03-4
-
Formula:
C42H38O20.Ca
-
Chemical Name:
[9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:1), (9R,9′R)-rel-
-
Synonyms:
[9,9′-Bianthracene]-2,2′-dicarboxylic acid,5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-,calcium salt (1:1),(9R,9′R)-rel-;[9,9′-Bianthracene]-2,2′-dicarboxylic acid,5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-,calcium salt (1:1),(R*,R*)-;Pursennide;Pursennid;Sennoside Ca;57762-65-9;73613-08-8
- Categories:
-
CAS No:
[9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:1), (9R,9′R)-rel- Basic Attributes
868.8
900.142584 g/mol
263-461-9
Safety Information
|Danger|H317 (100%): May cause an allergic skin reaction [Warning Sensitization, Skin]|P261, P272, P280, P285, P302+P352, P304+P341, P321, P333+P313, P342+P311, P363, and P501|Aggregated GHS information provided by 78 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Agents that produce a soft formed stool, and relax and loosen the bowels, typically used over a protracted period, to relieve CONSTIPATION. (See all compounds classified as Laxatives.)
Pursennid
Computed Properties
Molecular Weight:900.8
Hydrogen Bond Donor Count:10
Hydrogen Bond Acceptor Count:20
Rotatable Bond Count:9
Exact Mass:900.1425844
Monoisotopic Mass:900.1425844
Topological Polar Surface Area:354
Heavy Atom Count:63
Complexity:1550
Defined Atom Stereocenter Count:10
Undefined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
Benzenesulfonic acid, 5-formyl-2-hydroxy-, calcium salt (2:1)
63468-54-2
-
Carbamodithioic acid, N,N-dimethyl-, calcium salt (2:1)
20279-69-0
-
Arsonic acid, calcium salt (1:1)
52740-16-6
-
2-Naphthalenesulfonic acid, 6-[2-(2-hydroxy-1-naphthalenyl)diazenyl]-, calcium salt (2:1) Formula
73612-32-5
-
2-Naphthalenesulfonic acid, 6-hydroxy-5-[2-(4-methyl-2-sulfophenyl)diazenyl]-, calcium salt (1:1) Formula
96293-51-5
-
Phosphoric acid, calcium magnesium zinc salt (1:?:?:?) Formula
68052-05-1
-
2-Naphthalenecarboxylic acid, 4-[2-(5-chloro-4-methyl-2-sulfophenyl)diazenyl]-3-hydroxy-, barium calcium salt (1:?:?) Structure
85005-86-3
-
5-Thiazoleacetic acid, 4-(4-chlorophenyl)-2-phenyl-, calcium salt (2:1) Structure
85721-24-0
-
What is Hexanoic acid, 6-(acetylamino)-, calcium salt (2:1)
36392-66-2
-
What is Phosphonic acid, monooctyl ester, calcium salt (2:1)
62405-09-8
[9,9′-Bianthracene]-2,2′-dicarboxylic acid, 5,5′-bis(β-D-glucopyranosyloxy)-9,9′,10,10′-tetrahydro-4,4′-dihydroxy-10,10′-dioxo-, calcium salt (1:1), (9R,9′R)-rel-
SDSRequest for Quotation